PATENT CLAIM ANALYSIS

Application Number: 16211281
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "017700"]

Abstract:
Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.

Claim (Index 19):
The method of  claim 18 , where the neurological or mental health conditions comprise depression, memory loss, dementia, cognitive dysfunction, hearing loss, vision loss, neurologic pain, or combinations thereof.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 98.0
- Lexical Diversity: 1.43478
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14853932', '14599373', '14641432', '13859719', '13317613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7064615118335918
- 35 USC 102 Novelty (BERT): 0.5153783355837075
- Combined Prediction Score: 0.6873531942086034
- Mean Citation Score: 158.77304199999998
- Max Citation Score: 187.35057
- Similarity Product: 105.2392235827142

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test